Late-onset hypogonadism: the Asian experience

The majority of the world's population resides in Asia, where the elderly segment will comprise more than one third of its people in the next 50 years. The health and well-being of the aging male in Asia is receiving more attention as health care systems develop and mature. The concept of hormone therapy in association with virility and vitality has been rooted in Asian cultures for thousands of years. As with the rest of the world, interest in diagnosing and treating late-onset hypogonadism (LOH) is gaining enthusiasm with better scientific understanding of the effects of testosterone deficiency in the aging male. Asian researchers have been making progress, with more studies set to mature over the next few years, and they are keen to discover the variations in the Asian aging male. In this review, we present the current experience and guidelines from Asia in the field of LOH.